Biodesix, Inc.
BDSX
$0.4266
-$0.0198-4.44%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | 25.70% | 35.76% | 45.30% | 48.92% | 46.25% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 25.70% | 35.76% | 45.30% | 48.92% | 46.25% |
Cost of Revenue | 19.04% | 23.70% | 19.70% | 12.85% | 2.32% |
Gross Profit | 27.63% | 39.51% | 54.53% | 63.93% | 66.97% |
SG&A Expenses | 15.47% | 16.52% | 19.39% | 12.87% | 6.80% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 17.45% | 17.73% | 16.81% | 8.39% | 0.66% |
Operating Income | -2.27% | 9.83% | 17.04% | 28.51% | 36.00% |
Income Before Tax | 7.71% | 14.11% | 17.67% | 30.82% | 32.66% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | 7.71% | 14.11% | 17.67% | 30.82% | 32.66% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 7.71% | 14.11% | 17.67% | 30.82% | 32.66% |
EBIT | -2.27% | 9.83% | 17.04% | 28.51% | 36.00% |
EBITDA | 1.66% | 16.78% | 24.97% | 35.11% | 41.04% |
EPS Basic | 39.24% | 47.46% | 45.67% | 56.19% | 58.09% |
Normalized Basic EPS | 39.12% | 48.06% | 46.24% | 52.97% | 55.56% |
EPS Diluted | 39.24% | 47.46% | 45.67% | 56.19% | 58.09% |
Normalized Diluted EPS | 39.12% | 48.06% | 46.24% | 52.97% | 55.56% |
Average Basic Shares Outstanding | 47.87% | 62.96% | 57.55% | 57.58% | 55.73% |
Average Diluted Shares Outstanding | 47.87% | 62.96% | 57.55% | 57.58% | 55.73% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |